The phenotypes of four mutant Escherichia coli Trp repressor proteins with increased activities have been examined in vivo using the challenge-phage assay, an assay based on a positive genetic selection for DNA binding. These proteins, which differ by single amino acid changes from the wild type (Glu13-Lys, Glu18-Lys, Glu49-Lys and Ala77-Val), require less L-tryptophan than wild-type repressor for activation in vivo, and are super-aporepressors. However, none of the four mutant repressors binds DNA in a corepressorindependent manner. Three of the four mutant repressors (with Glu-Lys changes) are more active when complexed with tryptophan, and are superholorepressors. Challenge-phage assays with excess tryptophan rank the mutant holorepressors in the same order as determined by binding studies in vitro. Challenge-phage assays with limiting tryptophan reveal additional phenotypic differences among the mutant proteins. These results show that the challenge-phage assay is a robust assay for measuring the relative affinities of specific protein -DNA interactions in vivo.
INTRODUCTION
Tryptophan aporepressor, the product of the Escherichia coli trpR gene, is an allosteric regulatory protein. Aporepressor binds two molecules of the corepressor ligand, L-tryptophan, to assemble an active holorepressor complex (1) . Trp holorepressor binds at least five different specific sites on the E.coli genome, to inhibit transcription of the trp (2), trpR (3), aroH (4) , mtr (5, 6) and aroL (7) operons.
The binding of Trp repressor to its operators responds in a timely manner to changes in the physiological state of the cell. Unlike coliphage X repressor, which controls an 'on-off transcriptional switch, Trp repressor modulates the rate of transcription of the tryptophan biosynthesis {trp) operon over a wide range. This rheostatic control is achieved by the binding of multiple Trp repressor dimers to complex, tandem operators (8) .
Like the binding of Lac (9, 10) and X (11, 12) repressors to their operators, the binding of Trp repressor to its operators is not maximized (13) (14) (15) . Inall three cases, mutations which result in tighter-binding phenotypes have been isolated in both the operator site and the coding sequence for the binding protein.
Using a screen for super-repressors, Kelley and Yanofsky (13) isolated four different mutations that increase TrpR activity in vivo. When cells with a partial defect in tryptophan biosynthesis are starved for tryptophan, high-level expression of these mutant repressors inhibits growth, under conditions in which high-level expression of wild-type repressor does not. All four mutant proteins are made in wild-type amounts, have been purified, and have been assayed for their abilities to bind tryptophan, the trp operator, and non-operator DNA in vitro (16) (17) (18) .
Of these four changes, three (Glul8-Lys, Glu49-Lys and Ala77-Val) have been isolated as second-site revertants of mutations that decrease the activity of Trp repressor (19) . The ability of super-repressors to suppress primary site (trpR~) mutations is not allele-specific. The changes Glul8-Lys and Glu49-Lys are isolated as suppressors of different primary site mutations (19) , and the construction of double mutants with Ala77-Val shows that this change can suppress a number of different primary site mutations as well (unpublished results).
The Ala77-Val change is predicted to replace one hydrophobic side chain with another on the interior of the protein (20) (21) (22) (23) . In a previous report, we described the detailed analysis of mutants with Ala77 changes, using the challenge-phage assay to measure the DNA-binding activity of Trp repressor in vivo. We showed that seven different single amino acid changes of residue alanine 77 result in super-arjorepressors, mutant repressors that are more active than the wild-type protein when tryptophan is limiting. With excess tryptophan, many of these super-repressors are not super-holorepressors, but behave like the wild type in vivo; Val77 holorepressor behaves like the wild type both in vivo and in vitro (15, 18) . On the basis of these and other results, we have deduced that the Ala77-Val change decreases the affinity of aporepressor for non-operator DNA, yet does not affect the binding of holorepressor to operator or nonoperator DNA.
The other three super-repressor changes, Glul3-Lys, Glul8-Lys, and Glu49-Lys, are glutamic acid to lysine changes located on the surface of the protein in the multiple crystal structures of repressor (20, 21, 24, 25) . Thus, all three Glu-Lys changes are predicted to make the surface of Trp aporepressor more basic. Unlike Val77 holorepressor, the three holorepressors with surface charge changes do not bind operator DNA like wildtype repressor in vitro. All three mutant holorepressors show decreased rates of dissociation from operator DNA (18) . Presumably, these three changes improve the electrostatics of the holorepressor/operator interaction.
In this paper, we use the challenge-phage assay for DNA binding (14, 26, 27) to examine these Trp super-repressors. Although two of these proteins result in cell death when overproduced, we can define conditions for challenge-phage assays that permit us to rank the dependence of repression by the mutant proteins on both the amount of aporepressor produced, and the amount of tryptophan required for their activation. Challenge-phage assays in which we vary the level of expression of Trp aporepressor in the presence of excess tryptophan reveal the same order of affinities of these mutant repressors for the trp operator as that observed in vitro. Challenge-phage assays in which we vary tryptophan concentration rank the activities of these mutant proteins differently. Differences in the results of these two assays indicate that some of these mutant superrepressor changes affect multiple equilibria in the network of interactions between TrpR protein, tryptophan, operator DNA, and non-operator DNA. (14) carries a minimal reference-type trp operator, 5' GAACTA-GTTAACTAGTTC 3', controlling P22 ant gene expression. Recently, two independent biochemical studies (30, 31) have shown that this minimal operator, not an alternative (32) , reflects the correct dyad for the binding of repressor dimers. Plasmid derivatives of pRLK13 (13) were the kind gift of Charles Yanofsky. To construct an otherwise isogenic set of plasmids that express wild-type and mutant trpR genes from the inducible lacUVS promoter, the 434 bp BarriHl fragments from mutant derivatives of plasmid pRLK13 encoding aporepressors with the Glul3-Lys, Glul8-Lys, Glu49-Lys, and Ala77-Val changes were cloned into the unique BamHI site of plasmid pPY158 (14) . Plasmid pPY150 (14) was used to express the wildtype trpR gene.
MATERIALS AND METHODS

Challenge-phage assays
Infections with challenge phage were performed as described (14, 27) . To measure repression as a function of the amount of plasmid-encoded Trp aporepressor required for the efficient lysogenization of the challenge phage, overnight cultures of MS1868/F'tec7Q carrying plasmid pPY150 or each mutant plasmid were diluted 100-fold into LB medium with 50 /ig/ml ampicillin and various concentrations of IPTG (isopropyl-/3-Dthiogalactoside), and grown to a density of 4x 10 8 /ml at 37°C. Each culture was infected with challenge phage P22 Kn9 O-rej2 arc-H1605(am) at a multiplicity of 25 phage/cell. After adsorption of die phage for 15 min at 25°C, infected cells were diluted, and each serial dilution was plated on green tryptophan dropout medium with the same concentration of IPTG, ampicillin (100 Hg/ml), kanamycin (25 /ig/ml), and tryptophan (100 /ig/ml).
To measure repression as a function of the amount of tryptophan corepressor required for the efficient lysogenization of the challenge phage, overnight cultures of MS1868/F'/ac7 Q carrying plasmid pPY150 or each mutant plasmid were diluted 100-fold into LB medium with 50 jig/ml ampicillin and 10~6 M IPTG, and grown to a density of 4xlO 8 /ml at 37°C. Each culture was infected with challenge phage P22 Kn9 O-ref2 arcamH1605 at a multiplicity of 25 phage/cell. After adsorption of the phage for 15 min at 25°C, infected cells were diluted, and each serial dilution was plated on green tryptophan drop-out medium with 10~6 M IPTG, ampicillin (100 /ig/rnl), kanamycin (25 /tg/ml), and tryptophan at various concentrations. The numbers of kanamycin-resistant colonies were scored after incubation of the plates at 37°C for 48 h. Frequencies of lysogeny were calculated as the titers of kanamycin-resistant survivors divided by the titers of cells immediately prior to infection with phage (assayed on green plates with 100 /tg/ml ampicillin). Values given as frequencies of lysogeny and efficiencies of plating represent the averages of at least six determinations, and varied less than five-fold from experiment to experiment.
To show that mutant and wild-type repressors were made at similar steady-state levels in our challenge-phage assays, mutant proteins made in the Salmonella host after induction with IPTG were quantitated using an immunological (Western) assay as described by Arvidson et al. (15, 33) . No differences were found in the levels of wild-type and mutant super-repressor proteins produced after induction with 10~6 or 10~5 M IPTG (data not shown). In the interpretation of our data, we assume that these proteins are produced at wild-type levels under other conditions of induction.
RESULTS
The challenge-phage assay for Trp repressor binding
To examine the Trp repressor/operator interaction in greater genetic detail, we have measured the binding of Trp repressor to defined operator sites in vivo, using the challenge-phage assay (26) . Challenge phages are derivatives of temperate phage P22 that afford a positive selection for DNA binding. A challenge phage carries a cloned operator that places the binary developmental switch of P22 under die control of a protein that binds the operator; trp challenge phages carry versions of a minimal, consensus binding site for Trp repressor ( Figure 1) .
To measure the ability of wild-type Trp repressor to bind an operator, a repressor-producing Salmonella host is infected with a high multiplicity of a trp challenge phage, and die fraction of cells surviving infection is determined. Challenge phages selectively lysogenize host cells that produce a critical level of active holorepressor, and kill cells that do not. For the phage, the developmental choice between lysogenic and lytic pathways depends on the state of occupancy of its trp operator. Saturation of the challenge-phage operator with Trp repressor prevents transcription of the P22 ant gene, and favors the lysogenic development of the infecting phage and the survival of the infected host cells. Conversely, if a challenge-phage operator is free of repressor, ant transcription leads to lytic P22 development and the death of the infected host. Therefore, the efficiency of lysogeny of a Trp challenge phage is a measure of the relative occupancy of the challenge-phage operator in vivo.
The ability of a challenge phage with a trp operator to lysogenize a host that produces Trp repressor depends on the concentration of active holorepressor complex, and therefore depends on both the level of Trp aporepressor as well as the level of tryptophan corepressor (14) . In our host for the challengephage assay, aporepressor is produced at variable levels from the lacUV5 promoter; this promoter is controlled in turn by Lac repressor. The addition of die inducer, IPTG, to this host results in the inactivation of Lac repressor, and elevated expression of the trpR gene. Thus, the level of aporepressor produced by the host is modulated by the addition of different concentrations of IPTG. The level of corepressor in our assays is modulated by the addition of different concentrations of exogenous tryptophan.
To understand the phenotypes of mutant Trp super-repressors, we have used the challenge-phage selection in two different ways. To determine the relative activities of super-repressors as holorepressors, we have varied the level of Trp aporepressor in the presence of saturating tryptophan. We also varied the tryptophan (corepressor) concentration for host cells that produce the same level of aporepressor. This second set of challenge- phage assays provides us with a measure of the relative activities of these mutant super-repressors as aporepressors.
Three mutant super-repressors are super-holorepressors
As shown in Figure 2 , our host that produces wild-type Trp repressor (MS1868/F'/ac/2 (pPY150) is lysogenized by a challenge phage with an idealized operator only when higher levels of Trp repressor are produced; die efficiency of lysogeny increases more than 1000-fold with increasing IPTG concentration. In contrast, three hosts which produce the mutant Glul3-Lys, Glul8-Lys and Glu49->Lys repressors are lysogenized by the challenge phage at lower IPTG concentrations. As shown in Figure 2 , the four super-repressors may be ranked in the order Lys49 > Lys 18 > Lys 13 > Val77 = wild-type by this assay. The relative activities of super-repressors in die presence of excess tryptophan is the same in vivo as has been measured by binding studies in vitro (18) . This assay is complicated by the finding that, in the presence f high amounts of the inducer, IPTG, cells producing the Lysl8 and Lys49 mutant repressors are lysogenized by the challengephage more poorly than at lower IPTG concentrations. This is because overproduction of these mutant super-repressors is lethal to die growth of their Salmonella host, as is the case for up-mutant X repressors (11, 34) . As shown in Figure 3 , the efficiency of plating of uninfected hosts producing the mutant Lys 18 and Lys49 super-repressors drops at higher concentrations of IPTG. S.typhimurium host MS1868/F'lacfi cells with derivatives of plasmid pPY150 were infected with a high multiplicity of trp challenge phage at different IPTG concentrations, and kanamycin-resistant survivors were assayed as described in Materials and Methods: wt, wild type; EK13, Glul3-Lys; EK18, Glul8-Lys; EK49, Glu49-Lys; AV77, Ala77-Val. The efficiency of lysogeny (log survival, plotted vs. logflPTG]) is a measure of how well the phage-borne reference trp operator is occupied by plasmid-encoded Trp repressor. In this experiment, repressor binding in vivo is measured as a function of the increasing concentration of intracellular Tip repressor protein in the presence of excess tryptophan (100 /ig/ml); identical results were obtained with higher concentrations of exogenous tryptophan. Because corepressor is present in excess under these conditions, these dose-response curves allow us to rank the relative values of K^ for each mutant holorepressor. For comparison, values of K AT0 for each mutant determined in vitro by Hurlburt and Yanofsky (18) MSlS6S/F'lacfi cells with derivatives of plasmid pPY150 were grown in LB medium at 37°C to exponential phase, and the efficiencies of plating (log survival) of these cells were measured on green indicator plates with 100 /tg/ml ampicilUn at different IPTG concentrations (plotted on a log scale), and divided by the efficiency of plating on media without IPTG. Otherwise isogenic hosts producing the mutant Glu 13 -Lys and Ala77 -Val repressors gave results identical to those of the host producing wild-type (wt) repressor.
One possible explanation for why the mutant super-repressors are more active as holorepressors is that they are produced in higher amounts than the wild-type repressor. To rule out this possibility, we induced cells producing the wild-type and each of the mutant super-repressors, determined the relative amounts of repressor produced by each strain by Western immunoblot analysis, and found that all four mutant repressors are made at the same steady-state levels as wild type (data not shown). Thus, these proteins are made in amounts to that of the wild-type repressor in the Salmonella host, as well as in an E.coli host (18) .
All four mutant super-repressors are super-aporepressors
We also assayed how the frequency of lysogeny of hosts that produce each of the mutant aporepressors depends on exogenous tryptophan concentration, after infection with our reference-type challenge phage. As shown in Figure 4 , although all of the mutant aporepressors still require tryptophan as corepressor for activation, all of the mutant aporepressors require less tryptophan for activation than wild-type aporepressor. This second type of challenge-phage assay ranks the four super-repressor mutants in a different order: Lysl8, Val77 > Lysl3 > Lys49 > wild type. In particular, it is important to note that whereas the Lys49 holorepressor is more active than the Lys 13 and Lys 18 holorepressors, Lys 13 and Lys 18 proteins are more active than Lys49 when tryptophan (corepressor) is limiting. This result is surprising because all three mutant aporepressors with Glu-Lys changes bind tryptophan with affinities similar to that of wildtype aporepressor in vitro (18) .
DISCUSSION
The results of challenge-phage infections with excess tryptophan allow us to rank the activities of the four mutant holorepressors in the order: Glu49-Lys > Glul8-Lys > Glul3-Lys > Consequently, mutants with activities higher than the wild type under these conditions are called 'super-aporepressors' However, we do not wish to imply that mutant aporepressor species can effect repression under these conditions. Ala77-Val. Thus, the challenge-phage assay provides us with a robust measure of the relative affinities of specific DNA-binding proteins for their sites in vivo. The order of affinities of these mutant Trp holorepressors determined by the challenge-phage assay is the same order that has been determined in vitro (18) . Similar concordances are observed between the results of challenge-phage assays in vivo and measurements in vitro of the binding of wild-type Trp repressor to operators with modified base pairs (14, 35) , the binding of wild-type X repressor to modified operators (12, 36, 37) , the binding of mutant X superrepressors to the wild-type operator (11, 34, 38) , the binding of wild-type Cro repressor to modified operators (39, 40) , and the binding of wild-type and mutant Mnt repressors to wild-type and mutant operators (41, 42) .
With Trp repressor, a protein that is activated allosterically by the binding of ligand, the challenge-phage assay can provide us with additional information. This is because we can assay repression with the challenge phage under conditions in which the activating ligand for Trp repressor is limiting, and the relative activity of (ligand-free) Trp aporepressor contributes to phenotype. We can model the complexity of a binding situation in which corepressor is limiting, by considering the equilibrium relationships between the different states of intracellular TrpR protein under these conditions ( Figure 5 ).
When tryptophan is saturating, TrpR protein occupies three states, free holorepressor (AT), holorepressor bound to nonspecific DNA (ATD), and holorepressor bound to operator DNA (ATO). The activity of a holorepressor in vivo, like that of a ligand-independent repressor, is determined by its ability to bind operator DNA in the presence of the competing (non-specific) genomic DNA.
In vivo, what we presume to measure by the challenge-phage assay is the apparent equilibrium dissociation constant of holorepressor, which is related to these constants by the equation,
Non-specific DNA is in vast excess of operator DNA in vivo.
Experimentally, if the concentration of genomic (non-specific) DNA is held constant, Kapp is determined predominantly by the 'specificity ratio', the ratio between specific and non-specific binding constants, (KATO^ATD)"
-
If the steady-state levels of wild-type and mutant Trp repressors are the same, the challenge-phage assay with abundant tryptophan provides us with a relative measure of K^ in vivo. When corepressor is limiting, the situation is more complex (15) . TrpR protein is distributed among at least six different states involving aporepressor (A), tryptophan (T), non-specific DNA (D) and operator DNA (O). The Ala77-Val super-repressor change results in an aporepressor that requires less intracellular tryptophan for activation than wild type, and a holorepressor that has wild-type affinity for the operator (Figure 2 ). This change does not appear to affect the interaction of holorepressor (AT) with either specific (O) or non-specific (D) DNA, or the interaction of aporepressor (A) with tryptophan (T) (18) . The primary effect of the Ala77-Val change is to increase the magnitude of KAJJ, decrease the magnitude of K^m, and thereby depopulate the [AD] state. The Ala77-Val change may restrict the ensemble of accessible conformations of the protein to a subset that mimics the set of conformations assumed when tryptophan is bound (15) . Thus, the super-aporepressor phenotype of the mutant Val77 protein is not due to the increased affinity of this aporepressor for tryptophan, but rather to its altered interaction with non-specific DNA. This result points out the fact that changes in any of several different combinations of equilibria between aporepressor, tryptophan, specific DNA, and nonspecific DNA may lead to a super-aporepressor phenotype: greater activity than the wild-type protein under conditions where intracellular tryptophan is limiting.
Of the three Glu-Lys super-repressor changes, Glu49-Lys results in the greatest increase in the affinity of holorepressor for operator. The primary effect of this change in vitro is on the dissociation rate of repressor from operator DNA (17, 18) . The Glu49-Lys change affects the DNA-binding surface of TrpR protein. The crystal structure of die holorepressor/operator complex predicts that the Lys49 side chain should make new ionic or hydrogen bonds with phosphates or nucleotide functional groups in the minor groove of the central four base pairs of the operator, base pairs that are not contacted by repressor in the wild-type complex (23, 25) . The interaction of Glu49-Lys holorepressor with the operator is more salt-sensitive than that of wild-type, consistent with the idea that this change creates new electrostatic interactions (17) . The observation that the change affects the dissociation rate for complex formation in vitro more than die association rate argues that these new, favorable interactions do not participate dramatically in the rate-limiting step for the formation of the repressor/operator complex. Binding of holorepressor, therefore, may proceed along a kinetic padiway that involves at least two steps: a slower, rate-determining step; and, a faster, subsequent step in which Lys49 can contribute to the binding interaction. Alternatively, dissociation of the Lys49 holorepressor may not proceed along the same pathway as association.
Previous studies rank the three mutant holorepressors widi Glu-Lys changes in the same order of activity both in vivo (13) and in vitro (18) : Lys49 > Lys 18 > Lys 13 > wild-type. On the basis of these results, the phenotypes of these changes could be explained solely in terms of their effects on specific binding (K ATO ). However, our results that rank the dependence of these mutant repressors on tryptophan for activation complicate this picture, and suggest that at least one of the Glu-Lys changes affects an additional equilibrium involved in repressor binding. This is because the Glu 13-Lys and Glu 18-Lys mutants are more active than Glu49-Lys when tryptophan is limiting, yet less active than Glu49-Lys when tryptophan is in excess. Examination of the ability of these mutant proteins to bind DNA and tryptophan in vitro suggests that the constants K AT , K A0 , and K ATD are unchanged (18) . If we assume that these three values are constant for the Lysl3, Lysl8, and Lys49 proteins, then the values of KAD and K ADT must be different for at least one of these mutants.
Three models can account for our data. First, the phenotype of Glu-Lys49 repressor may be due solely to its affects on specific binding (K ATO ), and the Glu-Lys 13 and Glu-Lys 18 changes may increase K^ (like the Ala77-Val change) as well as decrease K ATO . Alternatively, the Glu-Lys 13 and Glu-Lys 18 changes may affect only specific binding (K ATO ), and the Glu-Lys49 change may affect (decrease) both KAD an d K A TO This phenotype would be the opposite of that of Ala77-Lys repressor, for which both KAD and K AT0 are likely increased relative to wild type (15) . Finally, all three changes may improve specific binding (K AT0 ), and affect Kyyj to different extents.
Although mutations resulting in both Glu 18-Lys and Glu49-Lys changes can be isolated as second-site suppressors of negative dominant mutations in the trpR gene, Glu49-Lys restores greater repressor activity to several mutants than Glul8-Lys (19) . Of four changes that improve the binding of X repressor, two surface Glu-Lys changes predicted either to result in a new phosphate contact or to improve dimerization (Glu34-Lys and Glu83-Lys, respectively) do not suppress a change which results in the loss of base-specific contacts (Lys4-Glu), whereas two changes predicted to create new, additional contacts with operator base pairs do (Gly48-Ser and Gly48-> Asn) (11, 34, 43) . Taken together, these results suggest that the Glu49-Lys change may result in new, specific contacts between Trp repressor and its operator.
